Increased C-reactive protein concentrations in never-treated hypertension
- 1 October 2003
- journal article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 21 (10) , 1841-1846
- https://doi.org/10.1097/00004872-200310000-00010
Abstract
To test whether the plasma concentration of C-reactive protein (CRP), a sensitive marker of systemic inflammation, is increased in patients with newly diagnosed, never-treated hypertension and whether blood pressure and its pulsatile component, pulse pressure, are correlated with plasma CRP concentration independently of a consistent number of cardiovascular risk factors. Cross-sectional study in a hospital outpatient hypertension clinic. A total of 135 newly diagnosed, never-treated patients with hypertension and 40 healthy matched non-hypertensive controls underwent office and 24-h blood pressure measurement and blood sampling for determination of plasma CRP and serum lipid concentrations. Plasma CRP concentration was greater in hypertensive individuals (1.85 mg/l, interquartile range 0.74–3.64) than in control individuals (1.01 mg/l, interquartile range 0.67–1.88; P = 0.02). In the entire population, CRP had a significant direct association with office systolic blood pressure and pulse pressure, but not with diastolic blood pressure. Among hypertensive patients, plasma CRP was related to 24-h systolic blood pressure (r = 0.28, P< 0.01) and pulse pressure (r = 0.32, P< 0.01), but not to diastolic blood pressure (r = 0.12, P> 0.2). CRP was also directly associated with body mass index (r = 0.25, P< 0.01), serum low-density lipoprotein cholesterol (r = 0.21, P = 0.03) and serum triglycerides (r = 0.21, P = 0.03). In the multivariate analysis, systolic blood pressure and pulse pressure, but not diastolic blood pressure, were significant predictors of plasma CRP concentration when a consistent number of cardiovascular risk factors was controlled for simultaneously. Systolic blood pressure and pulse pressure, but not diastolic blood pressure, are predictors of plasma C-reactive protein concentrations in patients with newly diagnosed, never-treated hypertension, irrespective of the potential proinflammatory action of traditional cardiovascular risk factors.Keywords
This publication has 33 references indexed in Scilit:
- Do atherosclerosis and type 2 diabetes share a common inflammatory basis?European Heart Journal, 2002
- Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlations with plasma endothelin-1International Journal of Cardiology, 2002
- Increased levels of transforming growth factor-β1 in essential hypertensionAmerican Journal of Hypertension, 2002
- Age and Duration of Follow-up as Modulators of the Risk for Ischemic Heart Disease Associated With High Plasma C-Reactive Protein Levels in MenArchives of internal medicine (1960), 2001
- Fifty years of Framingham Study contributions to understanding hypertensionJournal of Human Hypertension, 2000
- Elevated systolic blood pressure as a cardiovascular risk factorThe American Journal of Cardiology, 2000
- Endothelin-1 Induces Production of the Neutrophil Chemotactic Factor Interleukin-8 by Human Brain-Derived Endothelial CellsBlood, 1998
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Recommendations for the use of home (self) and ambulatory blood pressure monitoringAmerican Journal of Hypertension, 1996
- Circadian characteristics of circulating interleukin-6 in menJournal of Allergy and Clinical Immunology, 1995